Ignite Creation Date:
2025-12-25 @ 2:28 AM
Ignite Modification Date:
2026-03-05 @ 3:42 PM
Study NCT ID:
NCT03645434
Status:
COMPLETED
Last Update Posted:
2020-12-17
First Post:
2018-08-09
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Single Inhalation Dose Study to Assess Efficacy, Pharmacokinetics (PK), Safety and Tolerability of AZD8871 in Patients With Long-term Lung Diseases.
Sponsor:
AstraZeneca
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Chronic Obstructive Pulmonary Disease | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Moderate to severe COPD | View |
| None | Muscarinic receptor antagonist | View |
| None | β2 adrenoceptor agonist (MABA) | View |
| None | Long-acting muscarinic antagonist (LAMA) | View |
| None | Long-acting β2-agonist (LABA) | View |
| None | Inhaled long-acting bronchodilator | View |
| None | Small airways disease (obstructive bronchiolitis) | View |
| None | Parenchymal destruction (emphysema), | View |